Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × oblimersen × Clear all

NCT00047229 2017-11-08

Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms